Why do I have stomach pain with Wegovy?

Health & LifestyleNews
295

Listen to article (english)

Translate to Spanish or other 102 languages!

Stomach pain is a common side effect of Wegovy (semaglutide) that affects approximately 20% of patients in clinical trials. Image for illustration purposes
Stomach pain is a common side effect of Wegovy (semaglutide) that affects approximately 20% of patients in clinical trials. Image for illustration purposes

Mega Doctor News

- Advertisement -

Medical News Today

Stomach pain is a common side effect of Wegovy (semaglutide) that affects approximately 20% of patients in clinical trials. This discomfort usually occurs because the medication slows down gastric emptying, which means food stays in your stomach longer than usual. 

Most people who experience this side effect notice it during the first few weeks of treatment or immediately after a healthcare professional increases their dose.

- Advertisement -

Follow the link below to read the full story at Medical News Today:

https://www.medicalnewstoday.com/articles/drugs-wegovy-stomach-pain?utm_term=feedcontent&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2026-03-10&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f#How-to-get-rid-of-Wegovy-stomach-pain

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
What Parents Should Know About RSV
Next article
Flag Signing Event Honors Donors and Recipients Ahead of 2026 Transplant Games

More Articles

TMA Honors Georgetown Pediatrician for a Career of Distinguished Service 

The Texas Medical Association (TMA) has honored Georgetown pediatrician John W. Hellerstedt, MD, with the 2026 TMA Distinguished Service Award in recognition of his 45 years of exemplary service to patients, public health, and organized medicine.   

FDA Clears Path for Expanded Testosterone Therapy Options for Men

The U.S. Food and Drug Administration is taking an initial step to advance treatment options for men’s health by encouraging sponsors of approved testosterone replacement therapy (TRT) products to contact FDA for information if they are interested in pursuing a potential new indication for low libido in men with idiopathic hypogonadism (without a known cause).

Study Finds Persistent Barriers to Hormone Therapy for Cervical Cancer Patients

Most oncologists say they would prescribe hormone therapy to cervical cancer patients who experience early menopause from radiation treatment, but barriers are keeping many from doing so in practice, according to a new University of Kentucky Markey Cancer Center study published in JAMA Network Open.

STC opens Wellness Center at Health Science Professions Campus

South Texas College recently inaugurated a new Wellness Center at its Health Science Professions Campus in McAllen, giving students, faculty and staff free access to a space designed to support both physical and mental well-being.
- Advertisement -